Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-01 · accession 0001472827-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-03-01 | MYGN | Solaiman Shereen | CHRO | F - Tax | $4.61 | -1,675 | 109.3K | -2% | -$7,722 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | F | D | 1,675 | $4.61 | 109,288 | D | — | — | (F1) Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on February 27, 2026. |